Therapeutic Peptides: Challenges and Solutions for Drug Developers

Therapeutic Peptides: Challenges and Solutions for Drug Developers

Brought to you by Agilent Technologies

Overview

Therapeutic peptides, including GLP 1 receptor agonists, are transforming treatment for chronic conditions such as diabetes and obesity. However, scaling production and ensuring quality is a significant challenge. This eBook explores key considerations in peptide development and highlights advanced analytical tools and workflows that help drug developers optimize quality and accelerate time to market.

Key Objectives:

Describe why peptide drugs require rigorous raw material verification
Explore advanced LC/MS and 2D‑LC solutions for purity and sequence analysis
Highlight methods for confirming peptide integrity, including isomeric substitutions

Brought to you by:

Please complete the form to download the e-book.

Forwarded this link? Clear the form

*Please see Agilent’s privacy statement to learn more about how your personal data will be treated.

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.